FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
News|Articles|January 4, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 4, 2022
Author(s)Sydney Jennings
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the
How many people in the US have been vaccinated against COVID-19?
According to the CDC as of today, January 4, 2022, at 3:19 PM, EDT:
• 73.8% of total US population has received at least 1 dose
• 62.2% of total US population is fully vaccinated
• 62.2% of total US population is fully vaccinated
The 5 states/territories with the highest percentage of population fully vaccinated are:
1. Vermont: 77.7%
2. Puerto Rico: 77.2%
3. Rhode Island:76.8%
4. Maine: 76%
5. Connecticut: 74.9%
2. Puerto Rico: 77.2%
3. Rhode Island:76.8%
4. Maine: 76%
5. Connecticut: 74.9%
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, January 4, 2022 at 4:22 PM, EDT, there have been:
• 56 803 703 confirmed cases and
• 829 351 deaths
• 829 351 deaths
The 5 states with the highest total confirmed cases are:
1. California: 5 726 991
2. Texas: 4 803 050
3. Florida: 4 209 927
4. New York: 3 736 399
5. Illinois: 2 263 166
2. Texas: 4 803 050
3. Florida: 4 209 927
4. New York: 3 736 399
5. Illinois: 2 263 166
Deaths: California has the highest number of deaths due to COVID-19 with 76 598 reported fatalities, followed by Texas with 76 028 and Florida with 62 504.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 294 487 701 confirmed cases, 5 454 773 deaths, and 9 241 887 841 vaccine doses administered.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
ACOG's new guideline covers hormone therapy timing, neurokinin receptor antagonists, SSRIs/SNRIs, and nonpharmacologic options for menopause symptoms.
Post hoc LUCENT-2 and VIVID-1 analyses show more mirikizumab-treated patients reached steroid-free composite remission in UC and Crohn disease at 1 year.
The FDA granted Breakthrough Device designation to Natera's cell-free DNA multi-cancer early detection assay. What it means for primary care.
Most adolescents with sporadic colorectal cancer present with stage III or IV disease, and few have a family history, per data presented at AAP 2026.
Advertisement
Advertisement
Trending on Patient Care Online
1
Who Should Get a CGM? Expanding the Primary Care Candidate Pool
2
FDA Grants Breakthrough Device Designation to Natera's Multi-Cancer Early Detection Blood Test
3
ACOG Issues Expanded Guideline on Managing Menopause-Related Vasomotor, Sleep, and Mood Symptoms
4
Mirikizumab Linked to Higher Rates of Corticosteroid-Free Composite Remission in UC and Crohn Disease
5